SARS‐CoV‐2 respiratory viral loads and association with clinical and biological features
Autor: | Biguenet, Adrien, Bouiller, Kévin, Marty-Quinternet, Solène, Brunel, Anne-Sophie, Chirouze, Catherine, Lepiller, Quentin, Marty‐Quinternet, Solène, Brunel, Anne‐Sophie |
---|---|
Přispěvatelé: | Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])-Université de Franche-Comté (UFC), Laboratoire Chrono-environnement (UMR 6249) (LCE), Cholley, Pascal, Centre Hospitalier Régional Universitaire [Besançon] (CHRU Besançon), Laboratoire Chrono-environnement - CNRS - UFC (UMR 6249) (LCE) |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Male
Fibrinogen Gastroenterology MESH: Virus Shedding chemistry.chemical_compound 0302 clinical medicine COVID-19 Testing MESH: Aged 80 and over Nasopharynx Prealbumin MESH: COVID-19 030212 general & internal medicine Respiratory system MESH: Treatment Outcome Aged 80 and over MESH: Aged MESH: Anosmia [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology MESH: Middle Aged viral loads Middle Aged Viral Load 3. Good health Virus Shedding Infectious Diseases C-Reactive Protein Treatment Outcome [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology MESH: Young Adult MESH: Dyspnea MESH: RNA Viral Biomarker (medicine) RNA Viral 030211 gastroenterology & hepatology Female France medicine.symptom MESH: Viral Load Viral load medicine.drug Adult medicine.medical_specialty MESH: L-Lactate Dehydrogenase Anosmia 03 medical and health sciences Young Adult Virology Internal medicine Lactate dehydrogenase MESH: Prealbumin MESH: C-Reactive Protein medicine Humans MESH: SARS-CoV-2 Viral shedding [SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitology Aged MESH: Humans L-Lactate Dehydrogenase business.industry SARS-CoV-2 MESH: COVID-19 Testing COVID-19 MESH: Adult Confidence interval MESH: Male MESH: Nasopharynx MESH: France Dyspnea chemistry inflammation MESH: Fibrinogen business MESH: Female [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology |
Zdroj: | Journal of Medical Virology Journal of Medical Virology, Wiley-Blackwell, 2021, 93 (3), pp.1761-1765. ⟨10.1002/jmv.26489⟩ Journal of Medical Virology, 2021, 93 (3), pp.1761-1765. ⟨10.1002/jmv.26489⟩ Journal of Medical Virology, Wiley-Blackwell, 2020, ⟨10.1002/jmv.26489⟩ |
ISSN: | 0146-6615 1096-9071 |
DOI: | 10.1002/jmv.26489⟩ |
Popis: | International audience; To determine the distribution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) respiratory viral loads (VL) during the acute phase of infection and their correlation with clinical presentation and inflammation-related biomarkers. Nasopharyngeal swabs from 453 adult SARS-CoV-2-infected patients from the Department of Infectious Diseases, Besançon, France, were collected at the time of admission or consultation for reverse transcriptase polymerase chain reaction (RT-PCR) analysis. Clinical information and concentrations of biological parameters (C-reactive protein [CRP], fibrinogen, lactate dehydrogenase [LDH], prealbumin) were noticed. Mean respiratory VL homogeneously decreased from 7.2 log10 copies/ml (95% confidence interval [CI]: 6.6-7.8) on the first day of symptoms until 4.6 log10 copies/ml (95% CI: 3.8-5.4) at day 10 (slope = -0.24; R2 = .95). VL were poorly correlated with COVID-19 symptoms and outcome, excepted for dyspnea and anosmia, which were significantly associated with lower VL (p |
Databáze: | OpenAIRE |
Externí odkaz: |